Upstream Processing

Feb 01, 2009
BioPharm International
By BioPharm International Editors
Are disposable bioreactors effective for cell culture?
Dec 01, 2008
BioPharm International
No time for QbD? How to convince management to make it a priority.
Nov 01, 2008
BioPharm International
By BioPharm International Editors
A centralized quality control strategy may be the best solution.
Nov 01, 2008
BioPharm International
There could be a serious glut of commercial scale mammalian cell culture capacity over the next five years. Then again, there could be a significant shortage. It all depends on how things develop in expression technology, the new product pipeline, and corporate strategies.
Oct 02, 2008
BioPharm International
There are a number of specific characteristics to be considered when developing and manufacturing live bacterial vaccines.
Oct 01, 2008
BioPharm International
To achieve the right balance between disposable and reuseable options, companies must consider important technical and economic factors.
Oct 01, 2008
BioPharm International
By BioPharm International Editors
Avoid manufacturing failures by effective viral inactivation.
Oct 01, 2008
BioPharm International
The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.
native1_300x100
lorem ipsum